Top

Published in:

01-05-2013 | Breast Oncology

Effect of MRI on the Management of Ductal Carcinoma In Situ of the Breast

Authors: Melissa Pilewskie, MD, Carlie Kennedy, MD, Claire Shappell, PhD, Irene Helenowski, PhD, Denise Scholtens, PhD, Nora Hansen, MD, Kevin Bethke, MD, Jacqueline Jeruss, MD, Patricia Karstaedt, MD, Seema A. Khan, MD

Published in: Annals of Surgical Oncology | Issue 5/2013

Abstract

Introduction

The accuracy of breast magnetic resonance imaging (MRI) for detection of ductal carcinoma in situ (DCIS) has prompted recommendations for its routine preoperative use, but its clinical benefit is debated. We reviewed our experience with MRI in DCIS patients to assess the utility of MRI for surgical planning.

Methods

DCIS patients (2008–2010) were identified through a prospectively maintained database and grouped into MRI and no-MRI groups. The rates of additional biopsies, altered surgical management, and reoperation were compared. Additionally, DCIS size ascertained by mammography, MRI, and final pathology was compared.

Results:

Of 352 DCIS patients, 217 received MRI and 135 did not. The type of initial operation and number of reoperations were similar between the two groups, but successful breast conservation was more frequent in the no-MRI group (p = 0.06). The additional biopsy rate was 38 % in the MRI group versus 7 % in the no-MRI group; ≥2 additional biopsies were performed in 18 % of the MRI group and 2 % of the no-MRI group (p < 0.0001). These yielded a cancer diagnosis in 26 % of MRI and 33 % of no-MRI patients (p = 0.73). MRI was not superior to mammogram in detecting size of DCIS lesions preoperatively; 52 % of mammograms were accurate (within 1 cm) compared with 41 % of MRIs.

Conclusions

DCIS patients who undergo preoperative breast MRI are far more likely to undergo additional biopsies. Unless these can be demonstrated to lead to improved long-term outcomes, the utility of routine preoperative MRI in DCIS patients remains questionable.

Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350:1430–41.PubMedCrossRef

NIH State-of-the-Science Conference Statement on: diagnosis and management of ductal carcinoma in situ. NIH Consensus and State-of-the-Science Statements Volume 26, Number 2, 2009.

Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994;11:181–92.PubMed

Yamada T, Mori N, Watanabe M, et al. Radiologic-pathologic correlation of ductal carcinoma in situ. Radio Graphics. 2010;30:1183–98.

Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;41:150–51.CrossRef

Oshida K, Nagashima T, Ueda T, et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol. 2005;15:1353–60.PubMedCrossRef

Rosen EL, Smith-Foley SA, DeMartini WB. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J. 2007;13:545–50.PubMedCrossRef

Mossa-Basha M, Fundaro GM, Shah BA, Ali S, Pantelic MV. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation. Radio Graphics. 2010;30:1673–87.

Liu H, Peng W. MRI morphological classification of ductal carcinoma in situ (DCIS) correlating with different biological behavior. Eur J Radiol. 2011. doi:10.1016/j.ejrad.2010.12.084.

10.

Raza S, Vallejo M, Chikarmane SA, Birdwell RL. Pure ductal carcinoma in situ: a range of MRI features. AJR. 2008;191:689–99.PubMedCrossRef

11.

Facius M, Renz DM, Neubauer H, et al. Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imaging. 2007;31:394–400.PubMedCrossRef

12.

Rahbar H, Partridge SC, Eby PR, et al. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol. 2011;21:2011–19.PubMedCrossRef

13.

Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881–88.

14.

Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110–19.PubMed

15.

Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment MRI with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–95.PubMedCrossRef

16.

Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142:441–47.PubMedCrossRef

17.

Turnbull L, Brown S, Olivier C, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet. 2010;375:563–71.PubMedCrossRef

18.

Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.PubMedCrossRef

19.

Braun M, Polcher M, Schrading S, et al. Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer. Res Treat. 2008;111:179–87.PubMedCrossRef

20.

Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–73.PubMedCrossRef

21.

Tillman GF, Orel SG, Schnall MD, et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;30:3413–23.CrossRef

22.

Kuhl C, Khun W, Braun M, Schild H. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast. 2007;16:S34–44.PubMedCrossRef

23.

Morrow M. Magnetic resonance imaging in breast cancer one step forward, two steps back? JAMA. 2004;292:2779–80.PubMedCrossRef

24.

Houssami N, Hayes D. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59:290–302.PubMedCrossRef

25.

Adkisson CD, Vallow LV, Kowalchik K., et al. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Ann Surg Oncol. 2011;18:1678–83.PubMedCrossRef

26.

Allen LR, Lago-Tora CE, Hughes JH, et al. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol. 2010;17:2395–2400.PubMedCrossRef

27.

Itakura K, Lessing J, Sakata T, et al. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer. 2011;11:33–8.PubMedCrossRef

28.

Kropcho LC, Steen ST, Chung AP, et al. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast J. 2012;18:151–6.PubMedCrossRef

29.

Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082–88.PubMedCrossRef

30.

Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg. 2009;198:262–9.CrossRef

31.

Chung A, Saouaf R, Scharre K, Phillips E. The Impact of MRI on the treatment of DCIS. Am Surg. 2005;71:705–10.PubMed

32.

Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.PubMedCrossRef

33.

Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–49.PubMedCrossRef

34.

Brennan ME, Houssani M, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systemic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009;27:5640–49.PubMedCrossRef

35.

Gao X, Fisher S, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038–45.PubMedCrossRef

36.

Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin North Am. 2010;19:475–92.CrossRef

37.

Solin LJ, Orel SG, Hwang W, Harris EE, Schnall MD. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386–91.PubMedCrossRef

38.

Hwang N, Schiller DE, Crystal P, Maki E, McCready DR. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol. 2009;16:3000–09.PubMedCrossRef

Title: Effect of MRI on the Management of Ductal Carcinoma In Situ of the Breast
Authors: Melissa Pilewskie, MD
Carlie Kennedy, MD
Claire Shappell, PhD
Irene Helenowski, PhD
Denise Scholtens, PhD
Nora Hansen, MD
Kevin Bethke, MD
Jacqueline Jeruss, MD
Patricia Karstaedt, MD
Seema A. Khan, MD
Publication date: 01-05-2013
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 5/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-012-2771-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of MRI on the Management of Ductal Carcinoma In Situ of the Breast

Abstract

Introduction

Methods

Results:

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results:

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2013

Effectiveness of OK-432 (Sapylin) to Reduce Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Doing Away with the Rule of 10 %

Increasing National Mastectomy Rates for the Treatment of Early Stage Breast Cancer

Individualized Surgery: Gamma-Probe-Guided Lymphadenectomy in Patients with Clinically Enlarged Lymph Node Metastases from Melanomas

Comparison of Billroth I and Roux-en-Y Reconstruction after Distal Gastrectomy for Gastric Cancer: One-year Postoperative Effects Assessed by a Multi-institutional RCT

The Influence of Surgical Factors on Persisting Symptoms 3 Years after Esophageal Cancer Surgery: A Population-Based Study in Sweden